BBC vs. QQQ
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and QQQ (Invesco QQQ ETF) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while QQQ is a Nasdaq-100 fund tracking the NASDAQ-100 Index. Both are passively managed. Over the past 10 years, BBC returned 10.98%/yr vs 22.48%/yr for QQQ. A 0.52 correlation means they provide meaningful diversification when combined. BBC charges 0.79%/yr vs 0.18%/yr for QQQ.
Performance
BBC vs. QQQ - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 23.79% return, which is significantly higher than QQQ's 20.41% return. Over the past 10 years, BBC has underperformed QQQ with an annualized return of 10.98%, while QQQ has yielded a comparatively higher 22.48% annualized return.
BBC
- 1D
- 4.97%
- 1M
- 11.76%
- YTD
- 23.79%
- 6M
- 18.79%
- 1Y
- 151.23%
- 3Y*
- 26.34%
- 5Y*
- -0.15%
- 10Y*
- 10.98%
QQQ
- 1D
- -0.25%
- 1M
- 2.96%
- YTD
- 20.41%
- 6M
- 19.46%
- 1Y
- 40.91%
- 3Y*
- 27.47%
- 5Y*
- 16.94%
- 10Y*
- 22.48%
BBC vs. QQQ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 23.79% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
QQQ Invesco QQQ ETF | 20.41% | 20.77% | 25.58% | 54.86% | -32.58% | 27.42% | 48.62% | 38.96% | -0.13% | 32.66% |
Correlation
The correlation between BBC and QQQ is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.43 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.50 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.51 |
Correlation (All Time) Calculated using the full available price history since Dec 17, 2014 | 0.52 |
The correlation between BBC and QQQ shifts across timeframes, from 0.40 (1 year) to 0.52 (all time), reflecting how their relationship changes across market environments.
BBC vs. QQQ - Sectors Allocation Comparison
Sectors
BBC
QQQ
Healthcare
Basic Materials
-
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Technology
-
Utilities
-
Healthcare
BBC
QQQ
Basic Materials
BBC
-
QQQ
Communication Services
BBC
-
QQQ
Consumer Cyclical
BBC
-
QQQ
Consumer Defensive
BBC
-
QQQ
Energy
BBC
-
QQQ
Financial Services
BBC
-
QQQ
Industrials
BBC
-
QQQ
Real Estate
BBC
-
QQQ
Technology
BBC
-
QQQ
Utilities
BBC
-
QQQ
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. QQQ — Risk / Return Rank
BBC
QQQ
BBC vs. QQQ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Invesco QQQ ETF (QQQ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BBC | QQQ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.87 | ||
| Sortino ratioReturn per unit of downside risk | +1.56 | ||
| Omega ratioGain probability vs. loss probability | 1.55 | 1.41 | +0.14 |
| Calmar ratioReturn relative to maximum drawdown | 10.08 | 3.44 | +6.64 |
| Martin ratioReturn relative to average drawdown | 29.53 | 12.79 | +16.74 |
Loading charts...
Drawdowns
BBC vs. QQQ - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, smaller than the maximum QQQ drawdown of -82.97%. Use the drawdown chart below to compare losses from any high point for BBC and QQQ.
Loading charts...
Drawdown Indicators
| BBC | QQQ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -82.97% | +6.12% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -11.96% | -3.14% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -22.77% | -31.68% |
Max Drawdown (5Y)Largest decline over 5 years | -71.97% | -35.12% | -36.85% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | -35.12% | -41.73% |
Current DrawdownCurrent decline from peak | -20.54% | -0.99% | -19.55% |
Average DrawdownAverage peak-to-trough decline | -37.09% | -32.73% | -4.36% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.14% | 3.21% | +1.93% |
Volatility
BBC vs. QQQ - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 12.13% compared to Invesco QQQ ETF (QQQ) at 8.47%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than QQQ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | QQQ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.13% | 8.47% | +3.66% |
Volatility (6M)Calculated over the trailing 6-month period | 26.75% | 14.20% | +12.55% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.33% | 17.67% | +18.66% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.51% | 22.64% | +16.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.79% | 22.43% | +15.36% |
BBC vs. QQQ - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than QQQ's 0.18% expense ratio.
Dividends
BBC vs. QQQ - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.37%, more than QQQ's 0.49% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.37% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
QQQ Invesco QQQ ETF | 0.49% | 0.45% | 0.56% | 0.62% | 0.80% | 0.43% | 0.55% | 0.74% | 0.91% | 0.84% | 1.06% | 0.99% |
Frequently Asked Questions
BBC and QQQ have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (12.13%) compared to QQQ (8.47%). In terms of maximum drawdown, BBC dropped -76.85% vs QQQ's -82.97%.
On 10-year performance, QQQ leads with 22.48% vs 10.98% for BBC. On fees, QQQ is cheaper at 0.18% per year. On volatility, QQQ has been the lower-risk option at 8.47%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, QQQ has performed better with a 22.48% return vs 10.98%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
QQQ is cheaper with a 0.18% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.37%, compared with 0.49% for QQQ.
BBC is categorized as Health & Biotech Equities, while QQQ is Nasdaq-100. BBC tracks LifeSci Biotechnology Clinical Trials Index, while QQQ tracks NASDAQ-100 Index. They also come from different issuers: Virtus Investment Partners and Invesco. Their fees differ too: 0.79% for BBC and 0.18% for QQQ.
BBC currently has the higher Sharpe Ratio (4.20 vs 2.33), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and QQQ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer